Literature DB >> 8833021

Clinical use of sensitive assays for thyroid-stimulating hormone.

P A Masters1, R J Simons.   

Abstract

OBJECTIVE: To review the optimal use of sensitive assays for thyroid-stimulating hormone (TSH) by clinicians.
METHODS: The available literature pertinent to the clinical application of sensitive TSH testing was identified through a systematic MEDLINE search and reviewed. Selection of materials for inclusion was based on clinical validity of the data and relevance to the study question. SYNOPSIS: Sensitive TSH assays have contributed greatly to our basic knowledge of thyroid physiology and are a powerful clinical tool in the diagnosis and treatment of thyroid disease. The clinical applicability of these assays, as is our understanding of their appropriate use, is rapidly expanding. Based upon the best evidence and current understanding of thyroid physiology, strategies are presented for appropriate use of sensitive TSH assays in healthy outpatients, in patients who are likely to have a disturbed hypothalmic-pituitary-thyroid axis, and in patients on levothyroxane therapy.
CONCLUSIONS: Although many clinical questions regarding the use of sensitive TSH assays remain to be studied, it has emerged as a powerful tool for the diagnosis and management of thyroid disease. Optimal use of sensitive TSH assays requires an understanding of TSH physiology and measurement, coupled with appropriate application and interpretation in specific clinical settings.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8833021     DOI: 10.1007/bf02599589

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  100 in total

1.  Regulation of maternal thyroid during pregnancy.

Authors:  D Glinoer; P de Nayer; P Bourdoux; M Lemone; C Robyn; A van Steirteghem; J Kinthaert; B Lejeune
Journal:  J Clin Endocrinol Metab       Date:  1990-08       Impact factor: 5.958

2.  The cost-effectiveness of three thyroid function testing strategies for suspicion of hypothyroidism in a primary care-setting.

Authors:  J M Schectman; L G Pawlson
Journal:  J Gen Intern Med       Date:  1990 Jan-Feb       Impact factor: 5.128

3.  Induction of hyperthyroidism by interferon-alpha-2b.

Authors:  M Schultz; R Müller; A von zur Mühlen; G Brabant
Journal:  Lancet       Date:  1989-06-24       Impact factor: 79.321

4.  Immunoradiometric assay of thyrotropin in plasma: its value in predicting response to thyroliberin stimulation and assessing thyroid function in amiodarone-treated patients.

Authors:  W M Wiersinga; E Endert; M D Trip; N Verhaest-de Jong
Journal:  Clin Chem       Date:  1986-03       Impact factor: 8.327

5.  Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays.

Authors:  C A Spencer; D Schwarzbein; R B Guttler; J S LoPresti; J T Nicoloff
Journal:  J Clin Endocrinol Metab       Date:  1993-02       Impact factor: 5.958

6.  Plasma TSH and serum T-4 levels in long-term follow-up of patients treated with 131-I for thyrotoxicosis.

Authors:  A D Toft; W J Irvine; W M Hunter; J Seth
Journal:  Br Med J       Date:  1974-07-20

7.  Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness.

Authors:  P S Hamblin; S A Dyer; V S Mohr; B A Le Grand; C F Lim; D V Tuxen; D J Topliss; J R Stockigt
Journal:  J Clin Endocrinol Metab       Date:  1986-04       Impact factor: 5.958

8.  Hyperthyroxinemia with bradycardia and normal thyrotropin secretion after chronic amiodarone administration.

Authors:  S Melmed; K Nademanee; A W Reed; J A Hendrickson; B N Singh; J M Hershman
Journal:  J Clin Endocrinol Metab       Date:  1981-11       Impact factor: 5.958

9.  Difference in pituitary-thyroid feedback regulation in hypothyroid patients, depending on the severity of hypothyroidism.

Authors:  T Aizawa; Y Koizumi; T Yamada; M Tawata; H Nagata; T Izumiyama; K Yoshizawa
Journal:  J Clin Endocrinol Metab       Date:  1978-09       Impact factor: 5.958

Review 10.  Thyroxine therapy.

Authors:  A D Toft
Journal:  N Engl J Med       Date:  1994-07-21       Impact factor: 91.245

View more
  1 in total

1.  Resistance to thyroid hormone with missense mutation (V349M) in the thyroid hormone receptor beta gene.

Authors:  Ji Yon Kim; Eun Suk Choi; Jong Chan Lee; Kyung Uk Lee; Yeo Joo Kim; Sang Jin Kim; Yong Wha Lee
Journal:  Korean J Intern Med       Date:  2008-03       Impact factor: 3.165

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.